Trials / Completed
CompletedNCT00817076
Study of the Effectiveness and Safety of Desloratadine (Aerius) Syrup in Children With Allergic Skin Inflammation (P03475)
Evaluation of the Efficacy and Safety of Desloratadine Syrup in Childhood Atopic Dermatitis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Organon and Co · Industry
- Sex
- All
- Age
- 6 Years – 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study was to test the effectiveness and safety of desloratadine (Aerius) syrup in children with allergic skin inflammation. Patients took desloratadine syrup once a day for 28 days. Once a week, the doctor measured the patient's symptoms. This measurement is called SCORAD. The doctor also rated how much relief the patient got from treatment and recorded any side effects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | desloratadine | desloratadine syrup; 5.0 mL once daily for 28 days |
Timeline
- Start date
- 2003-03-01
- Primary completion
- 2003-07-01
- Completion
- 2003-07-01
- First posted
- 2009-01-06
- Last updated
- 2022-02-16
Source: ClinicalTrials.gov record NCT00817076. Inclusion in this directory is not an endorsement.